
ANI Pharmaceuticals, Inc.
ANIP·NASDAQ
Last updated as of 2026-05-30 17:48 EST. Stock price information is sourced from TradingView and reflects real-time market prices.
Insights
Calculator
News
ANIP stock price change
On the last trading day, ANIP stock closed at 79.91 USD, with a price change of -1.48% for the day.
Trade stock perpsTrending stocks
About Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn moreANIP key data
Previous close79.91 USD
Market cap1.82B USD
Volume48.15K
P/E ratio20.27
Dividend yield (TTM)0.00%
Dividend amount-
Last ex-dividend date-
Last payment date-
EPS diluted (TTM)3.94 USD
Net income (FY)71.37M USD
Revenue (FY)883.37M USD
Next report dateAug 12, 2026
EPS estimate2.030 USD
Revenue estimate263.89M USD USD
Shares float20.02M
Beta (1Y)0.86

ANI Pharmaceuticals, Inc. overview
Sector
Health technology
Industry
Biotechnology
CEO
Nikhil Lalwani
Headquarters
Baudette
Website
anipharmaceuticals.com
Founded
1996
Employees (FY)
970
Change (1Y)
+73 +8.14%
Revenue / Employee (1Y)
910.69K USD
Net income / Employee (1Y)
73.58K USD
ANIP stock price forecast
According to technical indicators for ANIP stock, the price is likely to fluctuate within the range of 79.96–88.91 USD over the next week. Market analysts predict that the price of ANIP stock will likely fluctuate within the range of 74.06–109.24 USD over the next months.
Based on 1-year price forecasts from 73 analysts, the highest estimate is 253.69 USD, while the lowest estimate is 56.85 USD.
For more information, please see the
ANIP stock price forecast
page.
Latest ANIP stock news
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Finviz2026-02-20 16:03:42
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Finviz2026-02-20 16:03:42
ANI Pharmaceuticals to Present at Upcoming Investor Conferences
Finviz2026-02-24 11:54:49
ADMA Q4 EPS Up 14% Y/Y, Revenues Gain From Strong Asceniv Performance
Finviz2026-02-26 16:57:15
ANI Pharmaceuticals Turns Profit, Rare Disease Sales Surge 50%
Finviz2026-02-27 14:48:12
TBPH Stock Plunges 26% on Failure of Late-Stage MSA Study
Finviz2026-03-04 16:37:04
Immunovant Stock Surges 17% in 3 Months: What's Driving It?
Finviz2026-03-05 18:42:10
LRMR Stock on the Move: What Sparked the 55% Jump in the Past Month?
Finviz2026-03-06 16:31:04
BMY Wins FDA Nod to Expand Sotyktu Label for Psoriatic Arthritis
Finviz2026-03-09 17:06:48
3 Reasons Why Growth Investors Shouldn't Overlook ANI (ANIP)
Finviz2026-03-09 17:48:46
XENE Stock Up as Azetukalner Meets Goal in Focal Onset Seizures Study
Finviz2026-03-10 16:34:27
JNJ Gets EU Nod for Expanded Use of Akeega in Prostate Cancer
Finviz2026-03-10 16:37:38
ANI Pharmaceuticals Announces Publication of NEW DAY Clinical Trial Results in Ophthalmology
Finviz2026-04-07 10:54:52
ANI Pharmaceuticals Announces FDA Approval and Launch of Isosorbide Mononitrate Tablet
Finviz2026-04-08 10:57:43
ANI Pharmaceuticals Announces the Launch of Carbamazepine Extended-Release Capsules
Finviz2026-04-13 10:54:42
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Finviz2026-02-20 16:03:42
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Finviz2026-02-20 16:03:42
ANI Pharmaceuticals to Present at Upcoming Investor Conferences
Finviz2026-02-24 11:54:49
ADMA Q4 EPS Up 14% Y/Y, Revenues Gain From Strong Asceniv Performance
Finviz2026-02-26 16:57:15
ANI Pharmaceuticals Turns Profit, Rare Disease Sales Surge 50%
Finviz2026-02-27 14:48:12
TBPH Stock Plunges 26% on Failure of Late-Stage MSA Study
Finviz2026-03-04 16:37:04



